
Mike Faddoul, Partner, Audit & Assurance, Crowe, makes the case that gross-to-net accounting deserves the same pre-launch rigor as commercial strategy.
An audit partner in Crowe LLP's life sciences practice with more than 33 years of experience serving public and private life sciences companies. He has extensive experience with SEC reporting, initial public offerings, internal control over financial reporting (ICFR), and other regulatory requirements. His clients range from smaller reporting companies to large accelerated filers, including companies with foreign operations.

Mike Faddoul, Partner, Audit & Assurance, Crowe, makes the case that gross-to-net accounting deserves the same pre-launch rigor as commercial strategy.